SCOTUS Rules Out Gene Patents

In June, academic researchers and clinical laboratories seeking to make a mark in the emerging fields of molecular diagnostics and personalized medicine were buoyed by the long-awaited ruling of the U.S. Supreme Court in the case of Association for Molecular Pathology (AMP) v. Myriad Genetics Inc., (2013).